These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 26261163)

  • 1. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients.
    Bibiloni R; Mangold M; Madsen KL; Fedorak RN; Tannock GW
    J Med Microbiol; 2006 Aug; 55(Pt 8):1141-1149. PubMed ID: 16849736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease.
    Ryan FJ; Ahern AM; Fitzgerald RS; Laserna-Mendieta EJ; Power EM; Clooney AG; O'Donoghue KW; McMurdie PJ; Iwai S; Crits-Christoph A; Sheehan D; Moran C; Flemer B; Zomer AL; Fanning A; O'Callaghan J; Walton J; Temko A; Stack W; Jackson L; Joyce SA; Melgar S; DeSantis TZ; Bell JT; Shanahan F; Claesson MJ
    Nat Commun; 2020 Mar; 11(1):1512. PubMed ID: 32251296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
    Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low counts of Faecalibacterium prausnitzii in colitis microbiota.
    Sokol H; Seksik P; Furet JP; Firmesse O; Nion-Larmurier I; Beaugerie L; Cosnes J; Corthier G; Marteau P; Doré J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1183-9. PubMed ID: 19235886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.
    Hansen R; Russell RK; Reiff C; Louis P; McIntosh F; Berry SH; Mukhopadhya I; Bisset WM; Barclay AR; Bishop J; Flynn DM; McGrogan P; Loganathan S; Mahdi G; Flint HJ; El-Omar EM; Hold GL
    Am J Gastroenterol; 2012 Dec; 107(12):1913-22. PubMed ID: 23044767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.
    Schäffler H; Kaschitzki A; Alberts C; Bodammer P; Bannert K; Köller T; Warnke P; Kreikemeyer B; Lamprecht G
    Int J Colorectal Dis; 2016 May; 31(5):961-971. PubMed ID: 26951181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.
    Walujkar SA; Kumbhare SV; Marathe NP; Patangia DV; Lawate PS; Bharadwaj RS; Shouche YS
    World J Microbiol Biotechnol; 2018 May; 34(6):76. PubMed ID: 29796862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.
    Alipour M; Zaidi D; Valcheva R; Jovel J; Martínez I; Sergi C; Walter J; Mason AL; Wong GK; Dieleman LA; Carroll MW; Huynh HQ; Wine E
    J Crohns Colitis; 2016 Apr; 10(4):462-71. PubMed ID: 26660940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.
    Forbes JD; Van Domselaar G; Bernstein CN
    Inflamm Bowel Dis; 2016 Apr; 22(4):817-25. PubMed ID: 26937623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificities of the fecal microbiota in inflammatory bowel disease.
    Sokol H; Seksik P; Rigottier-Gois L; Lay C; Lepage P; Podglajen I; Marteau P; Doré J
    Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India.
    Kabeerdoss J; Sankaran V; Pugazhendhi S; Ramakrishna BS
    BMC Gastroenterol; 2013 Jan; 13():20. PubMed ID: 23351032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.
    Takaishi H; Matsuki T; Nakazawa A; Takada T; Kado S; Asahara T; Kamada N; Sakuraba A; Yajima T; Higuchi H; Inoue N; Ogata H; Iwao Y; Nomoto K; Tanaka R; Hibi T
    Int J Med Microbiol; 2008 Jul; 298(5-6):463-72. PubMed ID: 17897884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.
    Walker AW; Sanderson JD; Churcher C; Parkes GC; Hudspith BN; Rayment N; Brostoff J; Parkhill J; Dougan G; Petrovska L
    BMC Microbiol; 2011 Jan; 11():7. PubMed ID: 21219646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.